Table 5.
Dyssynchrony as assessed by SD T2P LS in the 4CH view T2P quartiles
|
|||||
---|---|---|---|---|---|
Quartile 1 n=41 | Quartile 2 n=41 | Quartile 3 n=38 | Quartile 4 n=40 | P for trend | |
|
|||||
T2P (ms) | <36 | 36–58 | 58–86 | >86 | |
|
|||||
LVEDV Baseline (mL) | 88.1 ± 24.9 | 99.4 ± 37.2 | 103.9 ± 37.7 | 101.7 ± 36.8 | 0.06 |
LVEDV Change (mL) | 2.9 ± 14.0 | −1.8 ± 12.1 | 2.0 ± 16.4 | 4.9 ± 14.0 | 0.32* |
LVESV Baseline (mL) | 32.7 ± 10.0 | 41.1 ± 23.8 | 45.5 ± 25.7 | 46.1 ± 24.3 | 0.004 |
LVESV Change (mL) | 1.8 ± 9.5 | −0.8 ± 6.2 | 1.3 ± 9.9 | 4.0 ± 8.7 | 0.22* |
LV mass Baseline (g) | 181.4 ± 50.3 | 197.7 ± 58.4 | 209.4 ± 65.4 | 234.4 ± 73.3 | <0.001 |
LV mass Change (g) | −1.1 ± 11.8 | 1.0 ± 23.9 | −3.4 ± 30.1 | −2.6 ± 17.8 | 0.84* |
LAV Baseline (mL) | 62.8 ± 22.0 | 59.5 ± 21.9 | 60.6 ± 23.5 | 61.7 ± 21.8 | 0.91 |
LAV Change (mL) | 0.1 ± 9.4 | −0.8 ± 13.1 | 3.3 ± 15.4 | 4.3 ± 17.9 | 0.10* |
LVEF Baseline (%) | 62.7 ± 4.8 | 60.3 ± 7.5 | 58.2 ± 9.4 | 56.7 ± 10.2 | <0.001 |
LVEF Change (%) | −0.7 ± 6.1 | 0.6 ± 5.9 | −0.7 ± 5.2 | −0.4 ± 6.4 | 0.41* |
adjusted for the baseline measure and randomized treatment assignment.